Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-24

Clinical Trial Update: Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the Multidimensional Assessment of THYmic States (MATHYS) in bipolar disorder patients treated with olanzapine; the trial completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bipolar Disorder I or II | Phase 3 | Status: COMPLETED | Results posted: 2009-06-24